SRI 31215 is a Matriptase/Hepsin/hepatocyte growth factor activator (HGFA) triplex inhibitor and mimics the activity of HAI-1/2 (endogenous inhibitors of HGF activation). SRI 31215 has potent inhibitory activity against matriptase, hepsin and HGFA with IC50 values of 0.69 µM, 0.65 µM and 0.30 µM, respectively. SRI 31215 can be used for the research of cancer[1].
Molekulargewicht:
419.56
CAS Nummer:
[1832686-43-7]
Formel:
C25H33N5O
Target-Kategorie:
c-Met/HGFR
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
